Clinica Baviera Cash Flow Conversion Efficiency
Clinica Baviera cash flow conversion efficiency. Based on the latest financial reports, Clinica Baviera (CBAV) has a cash flow conversion efficiency ratio of 0.146x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€14.17 Million ≈ $16.57 Million USD) by net assets (€97.36 Million ≈ $113.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Clinica Baviera (2005–2024)
Cash flow conversion efficiency of Clinica Baviera from 2005 to 2024. This chart illustrates how Clinica Baviera's cash flow conversion efficiency has evolved over time, based on yearly financial data. View CBAV live share price for real-time trading data and today's change.
Clinica Baviera Cash Flow Conversion Ratio Explained
Clinica Baviera cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Clinica Baviera Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Clinica Baviera ranked by their cash flow conversion efficiency. Also see CBAV market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhe Jiang Headman Machinery Co Ltd
SHG:688577
|
0.075x |
|
Karnov Group AB
ST:KAR
|
0.108x |
|
ODP Corp
NASDAQ:ODP
|
0.109x |
|
Cydsa S.A.B. de C.V
MX:CYDSASAA
|
0.068x |
|
Sparekassen Sjaelland-Fyn A/S
CO:SPKSJF
|
0.107x |
|
Corsair Gaming Inc
NASDAQ:CRSR
|
0.045x |
|
Silence Therapeutics PLC
NASDAQ:SLN
|
0.039x |
|
Andersen Group Inc.
NYSE:ANDG
|
-0.135x |
Annual Cash Flow Conversion Efficiency for Clinica Baviera (2005–2024)
The table below shows the annual cash flow conversion efficiency of Clinica Baviera from 2005 to 2024. Review CBAV free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €98.36 Million ≈ $114.99 Million |
€62.76 Million ≈ $73.38 Million |
0.638x | +1.85% |
| 2023-12-31 | €92.28 Million ≈ $107.88 Million |
€57.81 Million ≈ $67.59 Million |
0.627x | -19.75% |
| 2022-12-31 | €68.37 Million ≈ $79.93 Million |
€53.38 Million ≈ $62.40 Million |
0.781x | -7.70% |
| 2021-12-31 | €55.39 Million ≈ $64.76 Million |
€46.86 Million ≈ $54.78 Million |
0.846x | +20.75% |
| 2020-12-31 | €44.90 Million ≈ $52.50 Million |
€31.46 Million ≈ $36.77 Million |
0.700x | -15.05% |
| 2019-12-31 | €30.80 Million ≈ $36.01 Million |
€25.40 Million ≈ $29.70 Million |
0.825x | +41.07% |
| 2018-12-31 | €28.76 Million ≈ $33.63 Million |
€16.81 Million ≈ $19.66 Million |
0.585x | -8.14% |
| 2017-12-31 | €24.88 Million ≈ $29.09 Million |
€15.83 Million ≈ $18.51 Million |
0.636x | -12.74% |
| 2016-12-31 | €18.57 Million ≈ $21.72 Million |
€13.55 Million ≈ $15.84 Million |
0.729x | +43.39% |
| 2015-12-31 | €21.31 Million ≈ $24.92 Million |
€10.84 Million ≈ $12.67 Million |
0.509x | +6.31% |
| 2014-12-31 | €20.20 Million ≈ $23.62 Million |
€9.66 Million ≈ $11.30 Million |
0.478x | +18.62% |
| 2013-12-31 | €25.35 Million ≈ $29.63 Million |
€10.22 Million ≈ $11.95 Million |
0.403x | +4.02% |
| 2012-12-31 | €20.86 Million ≈ $24.38 Million |
€8.09 Million ≈ $9.45 Million |
0.388x | -36.41% |
| 2011-12-31 | €23.83 Million ≈ $27.86 Million |
€14.53 Million ≈ $16.98 Million |
0.610x | -5.44% |
| 2010-12-31 | €22.40 Million ≈ $26.19 Million |
€14.45 Million ≈ $16.89 Million |
0.645x | +65.96% |
| 2009-12-31 | €20.87 Million ≈ $24.39 Million |
€8.11 Million ≈ $9.48 Million |
0.388x | -27.99% |
| 2008-12-31 | €19.02 Million ≈ $22.24 Million |
€10.26 Million ≈ $12.00 Million |
0.539x | -45.12% |
| 2007-12-31 | €19.88 Million ≈ $23.24 Million |
€19.54 Million ≈ $22.84 Million |
0.983x | +21.61% |
| 2006-12-31 | €19.49 Million ≈ $22.79 Million |
€15.75 Million ≈ $18.42 Million |
0.808x | -11.07% |
| 2005-12-31 | €14.34 Million ≈ $16.76 Million |
€13.03 Million ≈ $15.23 Million |
0.909x | -- |
About Clinica Baviera
Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics in Spain and Europe. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, farsightedness, presbyopia, cataract, retinal, plastic surgery, pediatric ophthalmology, glaucoma, strabismus, cornea, neuro-ophthalmol… Read more